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Sister chromatid cohesion is mediated by cohesin
and is essential for accurate chromosome segrega-
tion. The cohesin subunits SMC1, SMC3, and
Rad21 form a tripartite ring within which sister chro-
matids are thought to be entrapped. This event re-
quires the acetylation of SMC3 and the association
of sororin with cohesin by the acetyltransferases
Esco1 and Esco2 in humans, but the functional
mechanisms of these acetyltransferases remain
elusive. Here, we showed that Esco1 requires Pds5,
a cohesin regulatory subunit bound to Rad21, to
form cohesion via SMC3 acetylation and the stabili-
zation of the chromatin association of sororin,
whereas Esco2 function was not affected by Pds5
depletion. Consistent with the functional link be-
tween Esco1 and Pds5, Pds5 interacted exclusively
with Esco1, and this interaction was dependent on
a unique and conserved Esco1 domain. Crucially,
this interaction was essential for SMC3 acetylation
and sister chromatid cohesion. Esco1 localized to
cohesin localization sites on chromosomes
throughout interphase in a manner that required the
Esco1-Pds5 interaction, and it could acetylate
SMC3 before and after DNA replication. These re-
sults indicate that Esco1 acetylates SMC3 via a
mechanism different from that of Esco2. We propose
that, by interacting with a unique domain of Esco1,
Pds5 recruits Esco1 to chromatin-bound cohesin
complexes to form cohesion. Furthermore, Esco1
acetylates SMC3 independently of DNA replication.
INTRODUCTION
Sister chromatid cohesion conferred by the cohesin complex is
essential for accurate chromosome segregation [1, 2]. Cohesin
complex, which consists of structural maintenance of chromo-
somes 1 (SMC1), SMC3, and Rad21, is proposed to topologi-1694 Current Biology 25, 1694–1706, June 29, 2015 ª2015 Elsevier Lcally embrace both sister chromatids [3]. Rad21 binds to the
fourth cohesin core subunit, stromal antigen (SA), which contains
two paralogs (SA1 and SA2). Rad21 and SA proteins are further
associated with several other factors, including Pds5, Wapl, and
sororin, which enable cohesin rings to build, maintain, and
dissolve cohesion during cell-cycle progression [4, 5].
Cohesin is loaded onto chromosomes prior to DNA replication,
but recent reports suggest that cohesin loading alone is not
sufficient for cohesin-dependent tethering of replicated chromo-
somes. The loaded cohesin requires an additional ‘‘establish-
ment’’ step that involves theacetylationof apair of lysine residues
within SMC3 by the evolutionarily conserved cohesin acetyl-
transferases (CoATs) (Eco1 in budding yeast and Esco1 and
Esco2 in human) [6–15]. In metazoans, cohesion establishment
also requires association with sororin during DNA replication to
antagonize cohesin-release factor Wapl, and SMC3 acetylation
facilitates, but is not sufficient for, the association [16, 17].
The regulation of CoAT function has been explored in budding
yeast. Cohesion establishment occurs in S phase, when SMC3
is acetylated [12, 13, 18, 19]. Eco1 transiently binds to chromo-
somes during S phase in a manner that depends on a physical
interaction between Eco1 and PCNA [20], which is believed
to enable Eco1 to establish cohesion specifically between
identical sister chromatids at the DNA replication fork, although
Eco1 movement along chromosomes has not been directly
observed [19].
Unlike yeast, human SMC3 is acetylated before the recruit-
ment of PCNA [21], and there are two Eco1 orthologs, Esco1
and Esco2, which contain a vertebrate-specific divergent N ter-
minus followed by an evolutionarily conserved acetyltransferase
domain [14, 15]. Whereas both Esco1 and Esco2 are able to
acetylate SMC3 at K105 and K106 [7, 17], these Esco proteins
are differently regulated in humans. Esco2, like budding yeast
Eco1, binds to chromosomes only during S phase [15]. In
contrast, Esco1 is expressed throughout the cell cycle [15].
Importantly, neither Esco protein is able to fully compensate
for loss of the other, suggesting that the functions of these two
proteins are not completely redundant [15]. However, little is
known about the specificity of the functional mechanisms of
the two Esco proteins.
Here, we used genetic, biochemical, and genomic studies to
demonstrate that Pds5 depletion specifically abolishes thetd All rights reserved
Esco1-dependent cohesion pathway, that Pds5 interacts exclu-
sively with Esco1, and that Esco1 localizes to cohesin local-
ization sites throughout interphase by interacting with Pds5.
Intriguingly, Esco1 was able to acetylate SMC3 independently
of DNA replication. These findings led us to propose that
Esco1 acetylates SMC3 via a mechanism different from that of
Esco2 and that, by interacting with Esco1, Pds5 recruits Esco1
to chromatin-bound cohesin complexes to form cohesion.
RESULTS
Esco1 Requires Pds5 to Acetylate SMC3
To examine the relative contributions of the two Esco proteins to
SMC3 acetylation during cell-cycle progression, we depleted
these proteins from HeLa cells using small interfering RNA
(siRNA) (Figure S1A). The cells were synchronized in S phase or
G1phaseusingdouble-thymidineblockand release (FigureS1B).
We then analyzed the SMC3 acetylation with an antibody that
specifically recognizes SMC3 when K106 or both K105 and
K106 are acetylated (Figures 1A and 1B) [17]. Depletion of either
Esco1 or Esco2 reduced SMC3 acetylation by 14% and
31%, respectively, and depletion of both of these enzymes re-
sulted in an86% reduction in acetylation in S phase (Figure 1A)
[17]. In contrast, SMC3 acetylation was only slightly reduced by
Esco2 depletion (by 4%) but substantially reduced by Esco1
depletion (by 84%) in G1 phase (Figure 1B). Crucially, the
magnitude of this reduction is similar to that observed after simul-
taneous depletion of Esco1 and Esco2 (90% reduction). These
results indicated that SMC3 acetylation depends almost entirely
on Esco1 in G1 but requires both Esco1 and Esco2 in S phase.
Budding yeast Eco1 is known to physically interact with Pds5
[22]. Recent studies have reported that SMC3 acetylation re-
quires Pds5 in budding and fission yeast, and it requires
Pds5A and Pds5B in mouse embryonic fibroblasts [23–25],
although the molecular mechanisms underlying this requirement
are not clear. To test whether this aspect of Pds5 is conserved in
humans, we depleted the two Pds5 paralogs and analyzed
SMC3 acetylation (Figures 1A, 1B, S1A, and S1B). Simultaneous
depletion of the two Pds5 proteins reduced SMC3 acetylation
in S phase by 32%, and we observed a more substantial
(71%) reduction when these cells were synchronized in G1
phase. In G1 phase, individual depletion of Pds5A and Pds5B
reduced the levels by 43% and 49%, respectively. These
results indicated that human Pds5A and Pds5B regulate this
modification, at least partially, in a non-redundant manner. To
examine the functional overlap of Pds5 with the Esco proteins,
we simultaneously depleted Pds5 and either Esco1 or Esco2
and analyzed SMC3 acetylation (Figure 1A). Depletion of
Pds5A and Pds5B only slightly reduced SMC3 acetylation
upon Esco1 depletion, but co-depletion of Esco2, Pds5A, and
Pds5B resulted in a synergetic reduction. Crucially, the SMC3
acetylation level in cells depleted of Pds5A, Pds5B, and Esco2
was similar to that observed in Esco1 and Esco2 co-depleted
cells. These results indicated that Pds5A and Pds5B are essen-
tial for Esco1-dependent SMC3 acetylation.
To address whether the lack of Esco1-dependent SMC3 acet-
ylation in Pds5-depleted human cells is caused by defective de
novo acetylation or by a failure to block deacetylation by the
SMC3 deacetylase HDAC8, we depleted Esco1 or both Pds5ACurrent Biology 25, 169and Pds5B in asynchronous cells and measured SMC3 acetyla-
tion in the presence of the HDAC8 inhibitor PCI-34051 (hereafter
PCI). SMC3 acetylation increased rapidly in the presence of PCI
(Figure 1C), as reported [26], but was blocked upon individual
depletion of Esco1 and Pds5, suggesting that Pds5 promotes
de novo SMC3 acetylation.
Esco1 Can Acetylate SMC3 after DNA Replication
To test whether Esco1 acetylates SMC3 after DNA replication,
cells depleted of Esco1, Esco2, or Pds5 were arrested in G2/M
phase by the Cdk1 inhibitor RO3306 (Figures 1D and 1E). We
further treated these cells with PCI for 2 hr and found that PCI
increased SMC3 acetylation levels in G2/M-arrested cells, sug-
gesting de novo SMC3 acetylation after DNA replication. This in-
crease was unaffected by Esco2 depletion, but it was prevented
in cells depleted of Esco1 or Pds5. Postreplicative de novo
SMC3 acetylation therefore requires Esco1 and Pds5.
Esco1 Requires Pds5 to Stabilize the Chromatin
Association of Sororin
We tested whether sororin is involved in regulation of SMC3
acetylation (Figure S2A). Individual depletion of Esco1, Esco2,
and sororin only slightly affected SMC3 acetylation in G2
(<8% reduction) [17]. Interestingly, co-depletion of sororin and
Esco1, unlike co-depletion of sororin and Esco2, produced a
synergetic reduction (48%), indicating that sororin depletion
reduces Esco2 mediated-SMC3 acetylation in G2. We further
found that SMC3 acetylation levels in cells depleted of Esco1
and sororin were substantially increased by PCI (Figures S2B
and S2C). We concluded that Esco2, at least in part, retains its
acetyltransferase activity in sororin-depleted cells, but sororin
is essential for Esco2-mediated SMC3 acetylation in G2.
We then analyzed the contribution of Esco1, Esco2, and Pds5
to the recruitment of Wapl and sororin. We performed biochem-
ical fractionation experiments with extraction buffer containing
100 mMNaCl and observed little effect of depletion of Esco pro-
teins on the amount of Wapl on chromatin, whereas Pds5 deple-
tion reduced Wapl on chromatin (Figure S2D). The simultaneous
depletion of both Esco proteins had no major effect on the
amount of sororin on chromatin with the extraction buffer con-
taining 100 mM NaCl (Figure S2D), but it resulted in a reduction
of sororin on chromatin with 250 mM NaCl (Figures 2A and S2E),
indicating the promotion of chromatin association of sororin by
Esco1 and Esco2 [17]. Interestingly, the individual depletion of
Esco2, unlike that of Esco1, reduced sororin on chromatin (Fig-
ures 2A and S2F), indicating that Esco2 has a non-redundant
role in stabilizing the chromatin association of sororin, although
both Esco proteins contribute to the process. Pds5 depletion
had little effect on the chromatin association of sororin. Interest-
ingly, depletion of both Esco2 and Pds5 reduced sororin on
chromatin to a similar extent as the depletion of the two Esco
proteins, whereas the simultaneous depletion of Esco1 and
Pds5 had little effect (Figure 2A). These results indicated that
Esco1 and Pds5 stabilize the chromatin association of sororin
in the same pathway.
To validate the functional overlap of Esco1 with Pds5, we pre-
pared mitotic chromosome spreads from cells that had been
depleted of these proteins and analyzed the resulting chromo-
some morphology. Depletion of either Esco1 or Esco2 slightly4–1706, June 29, 2015 ª2015 Elsevier Ltd All rights reserved 1695
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increased the frequency of cells exhibiting precocious separa-
tion of sister chromatid, and we observed a further increase
when both Esco proteins were depleted (Figure 2B), confirming
a previous report [15]. The simultaneous depletion of Esco1,
Pds5A, and Pds5B produced no additive defects in the cohesion
pathway. Interestingly, however, Esco2 depletion resulted in an
enhanced synergetic defect upon depletion of Pds5A and
Pds5B. Moreover, the triple depletion of Esco2, Pds5A, and
Pds5B caused a massive precocious separation of sister chro-
matids. This defect was similar in magnitude to that observed
after simultaneous depletion of Esco1 and Esco2. These results,
along with our SMC3 acetylation data, indicated that Pds5A and
Pds5B are both required for Esco1 to establish cohesion.
Whereas Pds5 depletion efficiently prevented Esco1 function,
it is possible that the amount of Pds5 left after depletion is suffi-
cient to sustain chromatin association of sororin and/or to
mediate Esco2 function (Figure S1A).
Esco1 Physically Interacts with Pds5 via a Highly
Conserved Region
We tested whether Esco proteins physically interact with the
cohesin components. Virtually no interaction was detectable
between Esco proteins and SMC3, SA1, or SA2, whereas
both Esco1 and Esco2 weakly interacted with Rad21 (Figures
S3A–S3C; data not shown). Interestingly, FLAG-tagged
Esco1 (FLAG-Esco1) coimmunoprecipitated with considerable
amounts of Pds5A, whereas Pds5A was hardly detectable
upon coimmunoprecipitation with FLAG-tagged Esco2 (FLAG-
Esco2; Figure 3A), which is consistent with the observed func-
tional overlap between Esco1 and Pds5 (Figure 1). To locate
the Pds5-binding region in Esco1, we generated partial frag-
ments of Esco1 and measured the ability of each fragment to
interact with Pds5A (Figures S3D and S3E). This mapping exper-
iment indicated that the region containing residues 263–344 is
essential for the interaction of Esco1 with Pds5A. Interestingly,
amino acid sequence comparison showed that this region
contains highly conserved sequences among Esco1 orthologs
(Figure 3B). To test whether this domain plays a direct role in
interacting with Pds5, we took a site-directed mutagenesis
approach to generate several mutants of full-length Esco1 in
which triplet sequences within the Pds5-binding domain were
replaced with three alanine residues (termed 3A; Figure 3C).Figure 1. Pds5 Depletion Specifically Abolishes Esco1-Dependent SM
(A and B) Immunoblotting of lysates from untransfected () cells and cells transfec
2 days and were then synchronized in S phase (A) and G1 phase (B) by double-thy
control. SMC3-ac levels in cells transfected with siRNAs were normalized to S
independently. The representative immunoblotting results (upper) along with the
SMC3.
(C) Immunoblotting of lysates from untransfected () cells and cells transfected
presence or absence of the HDAC8 inhibitor PCI. Total levels of SMC1 served as
time point of untransfected cells. The experiment was performed three times indep
mean and SD of three experiments (lower) are shown.
(D) Schematic representation of the experimental protocol (left). Untransfected He
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and SD of three experiments (lower) are shown. See also Figure S1.
Current Biology 25, 169We then analyzed the ability of each mutant to interact with
Pds5A and found that 3A mutation of two regions, namely resi-
dues 302–304 and 315–317, attenuated the interaction, whereas
3A mutation at other sites had no effect. Esco1 also interacts
with Pds5B, and this interaction was also prevented by the
302–304 3A mutation (Figure 3D), whereas this mutation hardly
affected the Esco1-Rad21 interaction (Figure S3C). These re-
sults indicated that Esco1 presumably interacts with Rad21
and Pds5 through different Esco1 regions and that a domain
evolutionarily conserved among vertebrates is responsible for
the interaction between Esco1 and Pds5. Based on these exper-
iments, we hereafter refer to residues 263–344 of Esco1 as the
Pds5-binding (PDB) domain. We also generated partial frag-
ments of Pds5A and tested whether these fragments interact
with Esco1. We found that neither the N-terminal (residues
1–200) nor C-terminal (residues 1,191–1,337) regions of Pds5A
are essential for interaction with Esco1 (data not shown).
The PDBDomain of Esco1 Is Indispensable for Cohesion
To address whether the PDB domain of Esco1 is required for its
function, we constructed HeLa cell lines stably expressing
siRNA-resistant versions of wild-type or 302–304 3A mutant
(hereafter 3A mutant) GFP-tagged Esco1 (GFP-Esco1) (Fig-
ure 4A). We depleted either only endogenous Esco1 or both
endogenous Esco1 and Esco2 from these cells (Figures 4A,
4B, and S4A). As expected, depletion of Esco1 and simultaneous
depletion of Esco1 and Esco2 reduced SMC3 acetylation and
ectopic expression of wild-type Esco1 largely rescued the
reduction. However, the Esco1 3A mutant failed to rescue this
loss of SMC3 acetylation. Therefore, the PDBdomain is essential
for Esco1 to acetylate SMC3.
To test whether the Esco1 3Amutant retains acetyltransferase
activity, we prepared Sf9 insect cells in which SMC3 was coex-
pressed with wild-type or 3A mutant Esco1 (Figure 4C). SMC3
was acetylated by wild-type Esco1, and this reaction is abol-
ished by a G768D mutation in the conserved acetyltransferase
domain of Esco1, indicating that our measurements of SMC3
acetylation were sensitive enough to detect changes in the
acetyltransferase activity of Esco1. The Esco1 3A mutant acety-
lated SMC3 as efficiently as wild-type Esco1 (Figure 4C). More-
over, SMC3 acetylation by Esco1 is not increased by Pds5A
expression (Figure S4B). We conclude that Pds5 is not essentialC3 Acetylation
ted with the indicated siRNAs. HeLa cells were transfected with the siRNAs for
midine block and release. Total levels of SMC1 and SMC3 served as a loading
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Figure 2. Esco1 and Pds5 Promote the Chromatin Association of Sororin in the Same Pathway
(A) Chromatin fractionation of untransfected () cells and cells transfected with the indicated siRNAs. Cells that had been depleted of Esco and Pds5 were
synchronized in S phase by double-thymidine block and release. Cells were transfected with the Esco1 and Pds5 siRNAs before the first thymidine arrest and
Esco2 siRNA after the release from the first thymidine arrest. Histone H3 served as a loading control of the chromatin-enriched fraction (chromatin). Numbers
beneath sororin bands indicate quantification of sororin levels on chromatin normalized to histone H3 (H3) levels and untransfected cells. The asterisk indicates
nonspecific signals.
(B) Quantification of the percentage of mitotic HeLa cells exhibiting separated sister chromatids after combinational depletion of Pds5A and Pds5B (left), Esco1
and Pds5 (middle), and Esco2 and Pds5 (right). The experiments were performed twice independently, and representative Giemsa-stained mitotic chromosome
spreads of paired and separated sister chromatids after siRNA transfection (lower) are shown. One hundred cells per RNAi experiments were classified into two
groups in each experiment. Paired and separated chromatids were obtained from untransfected cells and cells transfected with both Esco1 and Esco2 siRNAs,
respectively. Hypercondensation phenotype, which is observed in mitotic chromosomes obtained from cells depleted of Esco1 and Esco2, may not be due to
depletion of Esco1 and Esco2, because this phenotypewas observed in separated chromosomes obtained from untransfected cells (data not shown). Bar, 10 mm
(see also Figure S2).for acetyltransferase activity of Esco1 and defective SMC3 acet-
ylation in the Esco1 302–304 3A mutant cells may not be due to
the loss of acetyltransferase activity of this mutant.
To further address whether the PDB domain of Esco1 contrib-
utes to cohesion, we prepared mitotic chromosome spreads1698 Current Biology 25, 1694–1706, June 29, 2015 ª2015 Elsevier Lfrom cells carrying the Esco1 3A mutant in place of endogenous
Esco1 (Figure 4D). Depletion of both Esco proteins caused a
pervasive precocious separation of sister chromatid, which
was largely rescued by ectopic wild-type Esco1, as expected.
However, the Esco1 3A mutant was less effective in this rescue.td All rights reserved
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Figure 3. Pds5 Preferentially Interacts with Esco1
(A) Interaction of Pds5A with Esco proteins. FLAG-Esco1 or FLAG-Esco2 was coexpressed with Pds5A in Sf9 insect cells using baculoviruses. Immunopre-
cipitates (IPs) obtained from cell lysates using anti-FLAG beads and input fractions were analyzed by immunoblotting.
(B) Conserved sequences within the Pds5-binding domain of orthologous Esco1 proteins from different species and Esco2 of humans. The two triplet-residue
sequences essential for Pds5 interaction are indicated by dashed rectangles.
(C) Interaction of Pds5A with a series of Esco1 mutants. FLAG-Esco1 wild-type (WT) or mutants were coexpressed with Pds5A in Sf9 insect cells and then
precipitated with anti-FLAG beads. The precipitates along with input fractions were analyzed by immunoblotting.
(D) Interaction of Pds5Bwith Esco1. Myc-tagged Pds5B (myc-Pds5B) was coexpressedwith FLAG-Esco1WT or the Esco1 302–304 3Amutant in Sf9 insect cells
with baculovirus. Immunoprecipitates obtained from cell lysates using anti-FLAG beads were analyzed by immunoblotting. The asterisks indicate possible
degradation products of myc-Pds5B (see also Figure S3).Taken together, we concluded that the PDB domain of Esco1 is
indispensable for cohesion.
Esco1 Colocalizes with Cohesin throughout Interphase
We next analyzed the distribution of Esco1 on chromosomes.
Because our Esco1 antibody was not effective for chromatin
immunoprecipitation (ChIP) (data not shown), we prepared
HeLa cells expressing siRNA-resistant versions of GFP-Esco1
at levels comparable to that of endogenous Esco1, and we
depleted only the endogenous Esco1. Immunoblotting revealed
that endogenous Esco1 was largely replaced by the GFP-Esco1
(Figure 5A). We then carried out a ChIP-sequencing (ChIP-seq)
assay with anti-GFP (Figures 5B and S5A) and identified
12,386 and 11,797 GFP-Esco1 sites in G1 and G2, respectively
(Table S1). Depletion of GFP-Esco1 eliminated the GFP-Esco1
ChIP-qPCR signals (Figure 6B), suggesting that most, if not all,
of the sites identified in the ChIP-seq were specific for Esco1.
The localization of endogenous Rad21 and Pds5A were also as-
sessed to map the cohesin localization sites (Figure 5B); 27,333
and 24,592 localization sites for Rad21 and Pds5A, respectively,
were identified in G1; and 29,958 and 24,127 Rad21 and Pds5A
localization sites, respectively, were identified in G2 (Table S1).
We classified the localization sites of GFP-Esco1, Rad21, and
Pds5A relative to genes (Figure S5B) and observed no major
enrichment of GFP-Esco1 localization sites in specific regions,
although GFP-Esco1 localization sites were slightly over-repre-Current Biology 25, 169sented in upstream and downstream region of genes (14% and
12% of GFP-Esco1 localization sites in G1 and G2, respectively)
compared to their frequency in the genome (8%). Similarly,
Rad21 and Pds5A did not preferentially localize to specific
regions, whereas most of yeast cohesin localization sites on
chromosome arms are regions of convergent transcription [27,
28]. Notably, we observed a high degree of overlap among
GFP-Esco1, Rad21, and Pds5A in both G1 and G2 (Figures
5B, 5C, S5C, and S5D), with most of the GFP-Esco1, Rad21
[29], and Pds5A sites being identical between these two phases
(Figures 5B, 5D, and S5E). Moreover, GFP-Esco1, like cohesin,
dissociated from these sites in prometaphase cells (Figures
5B, 5D, and S5E) [29–31]. Consistently, time course analysis of
GFP-Esco1 localization indicated that a considerable amount
of GFP-Esco1 localized to cohesin sites throughout DNA replica-
tion and dissociated from these sites in prometaphase (Figures
5E and S5F). We concluded that Esco1 colocalizes with cohesin
throughout interphase.
Pds5 Recruits Esco1 to Cohesin Localization Sites
We then tested whether chromatin loading of Esco1 depends on
cohesin. The amount of Esco1 on chromatin was not affected
by depletion of Pds5 or Rad21 (Figure S6A), and 302–304 3A
mutant Esco1 bound to chromatin as efficiently as wild-type
(Figure S6B), indicating that cohesin had no major effect on
the association of Esco1 with chromatin, at least under these4–1706, June 29, 2015 ª2015 Elsevier Ltd All rights reserved 1699
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Figure 4. The Pds5-Binding Domain of Esco1 Is Essential for Sister Chromatid Cohesion
(A and B) (Left) Immunoblotting analysis of lysates from cells carrying the Esco1 302–304 3A mutant in the place of endogenous (Endo.) Esco1. HeLa cells were
generated that stably expressed siRNA-resistant versions of wild-type GFP-Esco1 (WT) or GFP-Esco1 302–304 3A mutant. Two clones for each line were not
transfected () or transfected with Esco1 siRNA (A) or with both Esco1 and Esco2 siRNAs (B) for 2 days. The cells were grown asynchronously (A) or synchronized
in S phase by double-thymidine block and release (B). Lysates from these cells were then analyzed by immunoblotting. Tubulin is shown as a loading control (A).
The asterisk indicates nonspecific signals. (Right) Quantification of SMC3-ac levels in cells carrying the Esco1 302–304 3A mutant in the place of Endo. Esco1.
The experiments on the left were repeated twice, and SMC3-levels were normalized to cells expressing wild-type GFP-Esco1 (WT #1). The mean and SD of three
independent experiments are shown.
(C) Measurement of acetyltransferase activity of 302–304 3A mutant Esco1. His-tagged SMC3 (His-SMC3) was coexpressed with WT, 302–304 3A, or G768D
mutant His-tagged Esco1 (His-Esco1) in insect cells using the baculovirus expression system. Lysates from these cells were then analyzed by immunoblotting.
(D) Quantification of the percentage of mitotic HeLa cells exhibiting separated sister chromatids after the replacement of endogenous Esco1 with GFP-Esco1WT
or the GFP-Esco1 302–304 3A mutant. Cells were not transfected or transfected with both Esco1 and Esco2 siRNAs for 2 days and were examined by
chromosome spreads and Giemsa staining. The experiments were performed twice independently, and 100 cells per RNAi experiments were classified into two
groups in each experiment (see also Figure S4).
1700 Current Biology 25, 1694–1706, June 29, 2015 ª2015 Elsevier Ltd All rights reserved
assay conditions. This is consistent with a previous report that
an N-terminal fragment of Esco1, which was shown previously
to efficiently bind to chromatin, does not contain the PDB
domain [15].
We then utilized cells overexpressing GFP-Esco1 to address
whether Esco1 localization is regulated by cohesin (Figure S6C).
Our ChIP-seq analysis clearly showed that Pds5 depletion
substantially disrupted the localization ofGFP-Esco1 (Figure 6A).
We further measured the amount of GFP-Esco1 by ChIP-qPCR
at cohesin localization sites in cells depleted of Pds5 or Rad21.
Depletion of Pds5 or Rad21 reduced the amount of GFP-
Esco1 at cohesin localization sites (Figures 6B and S6D). It is
possible that the residual amount of Esco1 at cohesin localiza-
tion sites seen in our assay was due to incomplete depletion of
Pds5 or Rad21 (Figures 1A and S6A).
We also observed that Rad21 depletion reduced Pds5 on
chromatin (Figure S6A), as reported [32]. In contrast, Rad21
localization was only slightly affected by Pds5 depletion (Fig-
ure 6B), which prompted us to test whether Esco1 localization
depends on the interaction with Pds5. We then assessed the
localization of wild-type GFP-Esco1 and the GFP-Esco1 3A
mutant (Figures 6C and 6D). The enrichment of Esco1 at cohesin
localization sites was substantially reduced with the 3A mutant,
indicating that Esco1 is recruited to cohesin localization sites
via its PDB domain.
DISCUSSION
In the current model, cohesion establishment by Esco1 and
Esco2 depends on SMC3 acetylation, which facilitates the chro-
matin association of sororin [17]. Here, we showed that depletion
of the two Pds5 paralogs, Pds5A and Pds5B, prevented Esco1
from promoting the two events, whereas it did not affect Esco2
function. We propose that Esco1 and Esco2 acetylate SMC3
via different mechanisms and that Esco1 requires Pds5 to estab-
lish cohesion. Our biochemical analyses further showed that
Pds5 preferentially interacts with Esco1 and that this interaction
depends on an Esco1-specific domain, thus explaining how
Pds5 discriminates Esco1 from Esco2 to regulate SMC3 acety-
lation. The interaction of Esco1 with Pds5 was found to be
essential for Esco1 to localize to cohesin localization sites and
for cohesion, suggesting that Pds5 recruits Esco1 to cohesin
to establish cohesion.
Unexpectedly, Esco1 localization sites, which overlap with
cohesin localization sites, are identical between G1 and G2.
Whereas budding yeast Eco1 localizes to the DNA replication
fork in early S phase cells arrested by replication inhibitor
hydroxyurea [33], our results suggest that human Esco1 is
recruited to cohesin localization sites independently of DNA
replication, which is consistent with our finding of DNA replica-
tion-independent SMC3 acetylation by Esco1. Although Esco1
acetylates SMC3 independently of DNA replication, cohesion
establishment should occur specifically at DNA replication fork
in humans, because sororin loading, an additional requirement
for cohesion establishment, is coupled to DNA replication [17].
However, it is possible that postreplicative SMC3 acetylation
by Esco1 contributes to the reinforcement of cohesion after
cohesion establishment [33–36], although this hypothesis will
need to be verified in the future. It also will be interesting toCurrent Biology 25, 169test whether replication-independent SMC3 acetylation is
involved in transcriptional regulation [37].
Esco2 has a larger role than Esco1 in stabilizing chromatin
association of sororin, whereas the SMC3 acetylation level
in cells depleted of Esco2 was similar to that observed in
Esco1-depleted cells, suggesting that Esco2 stabilizes chro-
matin association of sororin through an unidentified event(s) in
addition to SMC3 acetylation. We also found that sororin is
essential for Esco2-mediated SMC3 acetylation in G2. Because
Esco2 appears to largely retain its acetyltransferase activity in
sororin-depleted cells, we suppose that Esco2 acetylates
SMC3 independently of sororin but the acetylated cohesin is
quickly reversed by HDAC8 in sororin-depleted cells, where co-
hesin is dynamically bound to chromatin [38]. These findings
further suggest that SMC3 acetylation and chromatin associa-
tion of sororin should be coupled at the DNA replication fork in
the Esco2-dependent cohesion establishment pathway.
Specific loss of cohesion at pericentric heterochromatin is
observed in Esco2-deficient mouse embryonic fibroblasts and
in cells isolated from patients of Roberts syndrome with
mutations in Esco2 [16, 39]; however, we have not observed
such defect in Esco2-depleted HeLa cells so far. This may be
explained by a difference in chromosome architecture between
these cell types. A recent study also reported that the amount
of chromatin-bound Esco2 is not altered but its specific localiza-
tion pattern is partially lost in Pds5-deficient mouse embryonic
fibroblasts [25], whereas Pds5 depletion did not affect the
Esco2-dependent cohesion pathway in HeLa cells. We specu-
late that the partial disruption of Esco2 localization in the
absence of Pds5 is not sufficient to affect its function. Alterna-
tively, there might be a functional difference between Pds5 in
human cancer cell lines and mouse embryonic fibroblasts,
although it is possible that Pds5 was inactivated to different
degrees in the two studies. A more-detailed characterization of
Esco2 is required to address these issues.
EXPERIMENTAL PROCEDURES
Cell Culture
HeLa cells were cultured as described [26] and were synchronized using a
double-thymidine block: 14–16 hr in the presence of 2 mM thymidine (Sigma),
8 hr release, and 16 hr in the presence of 1.5 mM thymidine. The cells were
collected 6–7.5 hr and 13 to 14 hr after the second release for enrichment in
G2 and G1, respectively. For the enrichment of cells in prometaphase, noco-
dazole (100 ng/ml or 400 ng/ml when used in combination with ZM447439)
was added 6 hr after release from the second thymidine block, and cells
were collected by the shake-off method.
Lentiviral Transduction
Recombinant lentiviruses were produced from 293FT cells transfected with
CSII-CMV-Venus (GFP variant)-Esco1 and packaging vectors (RIKEN Bio-
Resource Center). HeLa cells were incubated with recombinant lentivirus in
the presence of 10 mg/ml polybrene (Sigma).
Antibodies and Reagents
Polyclonal rabbit anti-sororin antibody was generously provided by Dr. J.M.
Peters (The Research Institute of Molecular Pathology). Rabbit polyclonal
antibody against Rad21 (for ChIP analysis), which was generated using
the peptides DEPIIEEPSR and ATPGPRFHII as immunogens, and a rabbit
polyclonal antibody against CAPD3 [40] were kindly provided by Dr. T. Hir-
ota (JFCR Cancer Institute). Mouse monoclonal antibodies were raised
against the following peptides: Esco1 (CEEKLPVIRSEEEKVRFERQKA),4–1706, June 29, 2015 ª2015 Elsevier Ltd All rights reserved 1701
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Figure 5. Esco1 Localizes to Cohesin Localization Sites throughout Interphase
(A) Immunoblotting analysis of lysates from cells carrying the GFP-Esco1 in the place of Endo. Esco1. HeLa cells were generated that stably expressed siRNA-
resistant versions of wild-type GFP-Esco1. The clone was not transfected () or transfected with Esco1 siRNA for 2 days, and lysates from these cells were then
analyzed by immunoblotting. Tubulin is shown as a loading control. The asterisk indicates nonspecific signals.
(legend continued on next page)
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Figure 6. Pds5 Is Essential for Esco1 to Localize to Cohesin Localization Sites
(A) Heatmaps showing ChIP-tag enrichment of GFP-Esco1 in the absence of Pds5 in a window of ±5 kb. This plot is centered on Esco1 peaks, and peaks are
ranked by size with the highest peaks at the top of the graph. HeLa cells expressing GFP-Esco1 were transfected with Pds5 siRNAs for 2 days and were then
synchronized in G2 by double-thymidine block and release.
(B) ChIP-qPCR data showing the amount of GFP-Esco1 or endogenous Rad21 at the cohesin-positive (P1 and P2) and -negative (N1) sites identified by ChIP-seq.
Indicated cells were not transfected () or transfected with each siRNA for 2 days and synchronized in S phase. The expression of both endogenous Esco1 and
GFP-Esco1 are suppressed by Esco1 siRNA. Chromatin obtained from these cells was immunoprecipitatedwith anti-GFP or anti-Rad21, and enrichment of GFP-
Esco1 and Rad21 was scored by qPCR, respectively. Values are the mean of two PCR amplifications.
(C) Immunoblotting analysis of the expression of WT and 302–304 3A mutant GFP-Esco1 in whole-cell extracts. Tubulin is shown as a loading control.
(D) ChIP-qPCR data showing the relative amount of WT and 302–304 3Amutant GFP-Esco1 at the cohesin-positive (P1 and P2) and -negative (N1) sites identified
by ChIP-seq. Cells in (C) were synchronized in G2 by double-thymidine block and release. Chromatin was obtained and immunoprecipitated with anti-GFP.
Enrichment of WT and 302–304 3A mutant GFP-Esco1 was scored by qPCR. Values are the mean of two PCR amplifications (see also Figure S6).pS302 (CEQAGKSKRGpSILQLCEEIA), Esco2 (CSASSKNKEKLIKDSSD
DRVSSKEHKVDKNE), Pds5A (CEAGNAKAPKLQDLAKKAAPAERQIDLQR),
and Pds5B (MAHSKTRTNDGKITYPPGVKEISDKISKEEMVRRC). The mouse
monoclonal antibody against the acetylated form of SMC3 has been
described [17]. Commercially obtained antibodies included anti-SMC3
(Abcam and Bethyl Laboratories), anti-SMC1 (Abcam), anti-tubulin (Sigma),
M2 antibody recognizing FLAG (Sigma), anti-histone H3 (Abcam), anti-
histone H3 S10 phosphorylation (Cell Signaling Technology), anti-Myc
(Millipore), anti-His tag (MBL), anti-Wapl (Proteintech Group), anti-Rad21
(for immunoblotting; Millipore), anti-GFP (for immunoprecipitation; Invitro-(B) Representative ChIP-seq data (RefSeq gene position 201.2–201.7 Mb of hum
shown in red. Binding profiles for GFP-Esco1, Rad21, and Pds5A are shown.
(C) Heatmaps showing ChIP-tag enrichment in the indicated ChIP-seq experimen
and G2 (right) are shown. Peaks are ranked by size with the highest peaks at the
(D) Heatmaps showing ChIP-tag enrichment of GFP-Esco1 in ChIP-seq experim
centered on GFP-Esco1 peaks observed in G1. Peaks are ranked by size with th
(E) ChIP-qPCR data showing the relative amounts of GFP-Esco1 at the cohesin-p
cycle progression. Cells expressing either GFP or GFP-Esco1 were synchronize
thymidine arrest, cells were harvested at the indicated time points and cell-cyc
cipitated with anti-GFP. Enrichment of GFP-Esco1 was scored by qPCR. Values
Current Biology 25, 169gen), and anti-GFP (for ChIP; Torrey Pines Biolabs). PCI-34051 was synthe-
sized by Synstar Japan. Nocodazole and RO3306 were obtained from
Calbiochem, BI2536 was from ChemieTek, and ZM447439 was from
TOCRIS Bioscience.
Quantification of Band Intensities in Immunoblotting
Band intensities were quantified using ImageQuant TL software (GE Health-
care). SMC3-ac levels were normalized to SMC1 or SMC3 levels. For the
analysis of chromatin association of sororin, sororin levels were normalized
to histone H3 levels in chromatin-enriched fraction.an chromosome 1). Regions in which signals were significantly enriched are
ts in a window of ±5 kb around all GFP-Esco1 peaks. Binding profiles in G1 (left)
top of the graph.
ents with G1, G2, and prometaphase cells in a window of ±5 kb. This plot is
e highest peaks at the top of the graph.
ositive (P1 and P2) and -negative (N1) sites identified by ChIP-seq during cell-
d at S phase entry by double-thymidine block. After release from the second
le profiles were obtained by FACS (Figure S4E). Chromatin was immunopre-
are the mean of two PCR amplifications (see also Figure S5).
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RNAi
RNAi was performed as described [26]. The sequences of the stealth siRNAs
(Invitrogen) used in this study are Esco1 siRNA (50-UGAAGUAUUUGUCUU
UCAACACUGG-30), Esco2 no. 1 siRNA (50-UUUAGGAACAACUUGCUGGA
AGCCC-30), Esco2 no. 2 siRNA (50-AUAACUUGCCAUCUGGUGUUGGGUC-
30 ), Esco2 no. 3 siRNA (50-AUACUUAGCAGUUAAACUCUUCUGU-30), Pds5A
siRNA (50-UAUUGUUGAUCACUGAGAAGAGAGU-30 or 50-AACAGUUAGCC
UCUGAUGUAGGCUG-30), Pds5B siRNA (50-UUAAUAAGAGCACUGAUAG
AUUCGG-30 ), sororin siRNA (50-AACUCCCGAGCAUCCUCCCUGAAAU-30),
and Rad21 siRNA (50-UUCCACUCUACUCUGAUUCAAGCUG-30).
Baculovirus Expression System
The cDNA of human Pds5B was obtained from the Kazusa DNA Research
Institute. The cDNAs of human Esco1, Esco2, Pds5A, and Pds5B were subcl-
oned into pFastBac-HTB (Invitrogen). Proteins were expressed using the
Bac-to-Bac baculovirus expression system (Invitrogen).
Fluorescence-Activated Cell Sorting
Cells were fixed with ethanol, washed with PBS, and stained for DNA with
propidium iodine. DNA profiles were analyzed using a FACSCalibur flow
cytometer and Cell Quest software (BD Biosciences).
Chromatin Fractionation Analysis for Sororin
Collected cells were washed with PBS and lysed on ice for 10 min in a buffer
consisting of 25 mM Tris-HCl (pH 7.5), 250 mM NaCl, 5 mM MgCl2, 10% (v/v)
glycerol, 0.2% (v/v) NP-40, 1 mM NaF, 10 mM sodium butyrate, and protease
inhibitor cocktail (Complete; Roche). Chromatin-enriched fractions were
collected by low-speed centrifugation at 1,5003 g for 5 min and were washed
with the same buffer.
Immunoprecipitation
For analysis of the Esco-Pds5 interaction, Sf9 cell pellets were resus-
pended in buffer (25 mM Tris-HCl [pH 7.5], 150 mM NaCl, 10% [v/v]
glycerol, 0.2% [v/v] NP-40, and Roche Complete protease inhibitor) for
10 min on ice. After removal of the insoluble fraction by centrifugation
at 20,400 3 g for 15 min, the remainder of each cell extract was used for
immunoprecipitation with agarose beads coupled to antibody M2 that
recognizes FLAG (Sigma). Precipitates were washed three times with the
same buffer.
For the identification of phosphorylation sites in Esco1 by mass spectrom-
etry, GFP-Esco1 was immunoprecipitated from cell extracts of nocodazole-
arrested mitotic cells or thymidine-arrested S phase cells. Cells were washed
with PBS and then lysed on ice for 15 min in a buffer consisting 25 mM Tris-
HCl (pH 7.5), 400 mM NaCl, 0.2% (v/v) NP-40, 10% (v/v) glycerol, and Roche
Complete protease inhibitor cocktail. Cell extracts, after removal of the insol-
uble fraction by centrifugation at 20,400 3 g for 30 min at 4C, were used for
immunoprecipitation. Protein A Dynabeads (Invitrogen) coupled to anti-GFP
(Invitrogen) were incubated with cell extract for 2 hr at 4C. Precipitates
were washed three times with the same buffer and resolved by SDS-
PAGE. The gels were stained with Quick-CBB PLUS (Wako Pure Chemical
Industries). Protein bands were excised from the gel, digested with Trypsin
Gold (Promega) or GluC (New England Biolabs), and analyzed by mass
spectrometry.
Chromosome Spreads
HeLa cells were grown asynchronously after siRNA transfection, and mitotic
cells were collected by shake-off and hypotonically swollen in a 1:1 solution
of PBS and tap water for 5 min at room temperature. Cells were fixed with
Carnoy’s solution (methanol:acetic acid; 3:1), dropped on glass slides, and
dried. Slides were stained with 5% (v/v) Giemsa (Merck), washed with water,
air-dried, and mounted with Entellan (Merck).
ChIP-qPCR
ChIP-qPCR was performed as described [26, 29] using the following primers:
P1: F, TAGACGGAGCTGGAAGGAAA
P1: R, AGGGACAGTCACCACCTTTG
P2: F, AAACCTCTGAGCTCATAATGCTG1704 Current Biology 25, 1694–1706, June 29, 2015 ª2015 Elsevier LtdP2: R, CTGGGTGCAAGCCACACT
P3: F, AAGAAGTCAAGATTTGGTAGCTTTT
P3: R, TCTCCAAGGACTGTGTGCAG
P4: F, GAGAAGAGGTTGTGCCTGGT
P4: R, TGGTTGCTTCTGGTTCACTG
P5: F, CTTGTGAAAGACGGTGCTTG
P5: R, CAGGGGTGAGAGGAAGGAG
N1: F, TTCTGCAACTAGGTAACACC
N1: R, ATAGGTTGGATTACATGATC
N2: F, ACTGTGGCTGGAAGATGAAT
N2: R, TGCCTTTATGATCATTTAGTGAGTChIP-Seq and Data Analysis
Deep sequencing of immunoprecipitated chromatin was performed using
the Illumina HiSeq 2500 system. Sequencing libraries were made using the
NEBNext ChIP-Seq Library Prep Master Mix Set for Illumina (New England
Biolabs). Single-end, 50-bp sequence reads for Rad21, Pds5A, and overex-
pressed GFP-Esco1 or 65-bp sequence reads for GFP-Esco1 with endoge-
nous levels were aligned to the human genome (UCSC hg19) using Bowtie
v1.0.0 [41] with the -n3 -m1 option, which reports only unique matches, allow-
ing three mismatches in the first 28 bases per read. All redundant reads (reads
starting exactly at the same position) were removed from further analysis.
DROMPA v2.5.3 [42] was used for visualization and statistical analysis of
ChIP-seq data. For peak-calling, we used PEAKCALL_P command, which
tested the significances of the ChIP-read enrichment (Poisson test) and the
ChIP/input enrichment (binomial test). We used p < 104 and p < 0.05 for Pois-
son test and binomial test, respectively. Sequencing, mapping data, and peak
calling statistics are summarized in Table S1. Gene annotation was obtained
from RefSeq. Heatmaps shown in Figures 5C, 5D, 6A, and S5D were created
using ngs.plot [43].
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